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1. Introduction 
Epilepsy surgery has had an impressive development over the years, becoming a first option 
for many patients who have refractory seizures. The results of conventional surgery are  
 
Fig. 1. Patients that are rejected from conventional epilepsy surgery 
This flow diagram shows the usual route a patient follows to undergo a surgical procedure. 
In red are shown those patients who are rejected from surgery. Almost all patients who have 
none lesional MRI (magnetic resonance imaging) are almost always rejected (dropouts) since 
the diagnostic procedure is complicated and the outcome is not very reassuring. Patients 
who have lesions are sometimes rejected too. This is due to an involvement of primary 
functions with high risk of postsurgical neurologic deficit. 
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excellent thanks to experience, and better diagnostic and surgical techniques. Nevertheless, 
there are a number of patients who are rejected due to several reasons, for example bilateral 
or multiple epileptic foci, focus involving primary functional areas of the brain, generalized 
seizures or non lesional imaging studies. It has been calculated that there is a 30% of patients 
who need surgery that have to be rejected. These patients need a surgical alternative, and 
neuromodulation might be the answer to many of them. (Figure 1). 
Even though neuromodulation has been proposed as an ideal surgical alternative for a 
number of neurological disorders, it’s application for the control of epileptic seizures would 
seem to be the most appropriate therapeutic indication since epilepsy is considered in most 
cases a functional disorder. Several targets have been proposed to control seizures. 
Although there might be discrepancies about which target is the best, all authors agree that 
neuromodulation improves seizure control without deteriorating neurological functions. 
Many studies have been performed in different epilepsy surgery centers in the world 
proposing several seizure types that respond, different and stimulation modes. This chapter 
intends to discuss a number of questions that arise in the use of this method.  
2. Who are the best candidates for neuromodulation? 
As with all surgical procedures that are used to treat refractory seizures, patient selection is 
the first step to ensure a good outcome. If we err to recognize the appropriate candidate, 
even the best surgery is a failure. This principle applies to neuromodulation. Furthermore, 
neuromodulation is expensive and needs high to be performed.  
In the future, neuromodulation might become the first option when considering a surgical 
method for refractory epilepsy. This is due to its low surgical risk and reversible qualities. 
But for now that ablative surgery is less expensive and shows good results. Criteria to select 
a patient are the following: 
 Primary generalized seizures  
 Multifocal or bilateral foci 
 Seizures arising from eloquent areas (motor, memory and language for example) 
In all the above clinical settings, conventional surgery has proven to be risky due to the fact that 
it can be a major surgery with high probability of infection, bleeding or loss of neural function. 
It is also less effective since surgeries tend to be restricted to avoid loss of function and hence 
residual seizures or relapses take place. If we add that there are a number of patients with non-
lesional MRI, the risk and outcome is worse and patients are discarded from surgical options.  
So the seizure type is decisive for the selection of the stimulation target. If we select a patient 
who has generalized seizures and we miss the fact that he has partial seizures with secondary 
generalized seizures, the patient will have a moderate improvement since generalized seizures 
will disappear but the partial and complex partial component will remain. So if we perform a 
seizure count, the number of seizures may turn out to be the same as before stimulation.  
There are other considerations that we have to take into account. This procedure will need 
follow-up for several weeks to ensure good results. It is convenient that the patient and his 
caregiver understand the importance of follow-up appointments. It is desirable that the 
patient lives near the epilepsy center or at least has easy access to personnel that can check if 
the stimulator is working appropriately or to adjust the stimulation parameters. They must 
www.intechopen.com
 Neuromodulation Advances for Seizure Control 
 
5 
be willing to return with the caregivers if stimulation fails to ensure proper function of the 
whole system (see follow-up section at the end of the chapter).  
 
Fig. 2. Surgical evaluation of the epileptic patient 
This figure depicts the clinical flow starting from the moment a patient is considered a 
surgical candidate. Presurgical evaluation in our Epilepsy Clinic includes a detailed medical 
history, EEG, in some cases video EEG with or without sphenoidal electrodes, MRI, 
PET/SPECT, functional MRI and neuropsyhcological testing. The extrasurgical evalation 
refers to phase II testing that includes continuous video EEG monitoring and brain mapping 
with electrical stimulation. Follow up includes the postsurgical testing: EEG, MRI, 
neuropsychological batteries. 
Patient and caregivers must also have a clear idea of what to expect. Seizures do not 
disappear as soon as the stimulator is turned on. There is a variable period of time to obtain 
seizure reduction. This period of time varies according to the stimulated target and 
stimulation mode. If the cerebellum or vagus nerve are chosen, the best effect will take years 
to be reached, if the thalamus is stimulated, seizure reduction will take from 3 to 6 months 
to be achieved, if the target is hippocampal focus, the time span is reduced to 2 to 6 weeks if 
the hippocampus shows no signs of sclerosis in the MRI. If we stimulate the cortical 
epileptic focus in a programmed cyclic mode, seizures diminish in a matter of days (Velasco 
et al 2009) and if the mode is based on a closed loop fashion seizures take months to years to 
decrease (Fountas and Smith 2007). 
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3. What target should we stimulate? 
Multiple targets that intend to achieve seizure reduction have been stimulated. At a first 
glance the amount of targets can be overwhelming and difficult to figure out. But basically, 
the different targets have been chosen based either on the idea of interfering with seizure 
propagation or generation (figure 3). 
  
Fig. 3. Neuromodulation targets in epilepsy 
Diagram shows some of the different targets for neuromodulation in epilepsy. In red are 
those targets whose stimulation interferes with seizure propagation: paravermian portion of 
the cerebellum (CER), vagus nerve (VAG), centromedian nuclei (CMN) and anterior nucleus 
(ATN) of the thalamus, subthalamic nucleus (STN). In green are the areas where epileptic 
foci can be located and stimulated to interfere with seizure generation: hippocampus (HIP), 
supplementary motor area (SMA), motor cortex (MCx) 
3.1 Interfering with seizure propagation 
This scope seems natural in generalized seizures but it has also been used in cases of partial 
seizures. In these scenarios, the rationale to select a target in which stimulation interferes with 
seizure propagation seems quite attractive. Several targets have been proposed: cerebellum, 
vagus nerve, thalamus (anterior, centromedian), and others such as subthalamic nuclei. 
In 1973 the first report that suggested that low frequency stimulation of the cerebellar cortex 
(dorsal paravermian area) decreased seizures in humans was published (Cooper et al, 1973). 
The idea of stimulating the cerebellum was based in experimental findings in epileptic 
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seizures induced in cats (Dow et al 1962). Even though results were controversial at first, a 
review of different studies with a total of 129 patients showed that 49% had significant 
seizure reduction, 27% being seizure free. This and other studies (Velasco et al 2005) have 
shown that the seizure type that best responds is primary generalized tonic clonic seizures 
and atypical absences and that even though there is an initial seizure reduction within the 
first two months of stimulation, the effect is not only maintained but there is a further 
decrease with time.  
Vagus nerve stimulation is not very invasive since reaching the nerve at the neck level is a 
relatively simple procedure. It has been used in all types of refractory seizures. Its effects on 
seizure reduction are modest (~ 30 %). Even though the precise antiepileptic mechanism 
remains unclear, it appears that the thalamocortical relay neurons modulate cortical 
excitability, influencing seizure generation or propagation (Ben-Menachem 2002). It can 
produce dysphonia, headache and increases peptic ulcer and insulin dependant diabetes 
mellitus. It is not recommended for children under 12 years old. 
According to the centro-encephalic theory by Penfield and Jasper (1954) high frequency 
stimulation of non-specific thalamic nuclei (such as centro-median or anterior thalamic 
nuclei) interferes with propagation of cortical or subcortically-initiated seizures. In 1984 
Velasco et al performed the first bilateral centromedian electrode implantation in a 12-year-
old boy with severe generalized seizures of the Lennox-Gastaut Syndrome. There was a 
considerable seizure reduction and impressive improvement in his intellectual status. Five 
years later they published a report of children and adults with generalized seizures of the 
Lennox-Gastaut Syndrome (Velasco 1989). The best results are obtained in the parvocellular 
portion. Neurophysiologic definition of the target is mandatory. This definition is based on 
electro cortical responses elicited by stimulation of the electrode contacts within different 
zones of the centromedian nucleus (Velasco F et al 2000, Velasco AL et al 2006). CM 
stimulation is more effective in generalized seizures and epilepsia partialis continua. When the 
patient selection as well as the anatomic and neurophysiologic criteria regarding the target 
localization are optimal, the results are >80% seizure reduction, some patients have become 
seizure free. An improvement in ability scales is also observed with no adverse effects. 
As described above, the anterior nucleus is a non-specific thalamic nucleus and as such, 
interferes with propagation of cortical or subcortical initiated seizures but it also interferes 
with seizures initiated in mesial temporal structures and propagated through the fornix, 
mammillary body and anterior nucleus of the thalamus (Mirski and Fisher 1994). The 
SANTE study Group has reported the results of the bilateral stimulation of the anterior 
nucleus of the thalamus (Fisher et al 2010). Its best results have been obtained in complex 
partial and secondary generalized seizures, wich were reduced reduced by stimulation. By 2 
years, there was a 56% median percent reduction in seizure frequency. 
The subthalamic nucleus has been stimulated for seizure control based on the suppressive 
effects of pharmacological or electrical inhibition of the STN seen on different types of 
seizure in animal models of epilepsy (Chabardès 2002). It is considered that inhibition of the 
subthalamic nucleus causes activation of an endogenous epilepsy control system referred to 
as the nigral control of epilepsy system (Gale and Iadarola 1980). Patients with frontal lobe 
and myoclonic seizures are the best responders. Improvement varies from 30 to 80% (Vesper 
et al 2007). Mild facial twitching and paresthesias in legs and arms responded to adjustment 
of the stimulation parameters. 
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3.2 Interfering with seizure generation 
Neuromodulation of the CM nuclei had already demonstrated anticonvulsive effects by 
stopping secondary tonic clonic generalized phase in patients with intractable mesial 
temporal lobe epilepsy but unfortunately it spared complex partial component that 
originated in the hippocampus (Velasco 1993a), thus patients continued to have disabling 
epilepsy. Based on the studies of Weiss et al (1998), Velasco et al (2000) started a project to 
demonstrate that the hippocampal stimulation would be a better alternative than trying to 
interfere with epileptic activity propagation.  
Various authors (Boon et al 2007, Velasco et al 2007) have shown the beneficial effects in 
seizure reduction in patients with hippocampal foci stimulation; best responders are those 
patients whose epileptic focus can be pinpointed with hippocampal electrodes and thus 
stimulated directly and have non-lesional MRI. In these latter cases seizure reduction is 
>90% with several patients being seizure free.  
Wyckhuys T et al (2007) found that high frequency stimulation of the hippocampus in 
kindled rats increases after-discharge thresholds with the consequent seizure reduction. 
There are some studies that have shown evidence that neuromodulation works by inhibiting 
the stimulated area. Clinical studies using neurophysiologic testing, single positron 
emission tomography and benzodiazepine receptor binding studies show that an inhibitory 
mechanism could explain seizure control (Velasco 2000, Cuéllar-Herrera 2004). Based in 
these observations, another challenge for epileptologists, the presence of intractable partial 
seizures arising from eloquent areas, was approached.  
Cortical stimulation for motor seizures has been performed in two modes: an open (Velasco 
et al 2009) and closed loop (Sun et al 2008). The first step is to localize the epileptic focus 
implanting first a diagnostic grid and when done, implanting a permanent electrode 
directed to the focus. In case of the open loop mode, a significant (>90%) seizure decrease 
takes place over several days and effect persists thereafter, the stimulation mode is pre-
established in a 24 hr cyclic 1 min ON, 4 min OFF. When the closed loop mode is used a 
seizure detection system is implanted too so that every time a seizure is detected, the 
stimulation therapy is delivered. In the latter mode, seizure reduction takes a longer period 
of time to produce a modest difference.  
 
Interfering with: Target % seizure reduction 
Propagation Vagus nerve 30 
 Centromedian nuclei 80-100 
 Anterior nuclei 56 after 2 years 
 Subthalamic nuclei 30-80 
   
Generation Hippocampal foci 80-100 
 Motor foci 90-100 
Table 1. Percentage seizure reduction  
This table shows the percentage of seizure reduction according to the different targets. Note 
that the percentages are approximate and might vary according to the different techniques 
explained in the text. 
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4. How do we set the neural stimulation? 
4.1 Verifying the chosen target 
No matter what target we choose we must consider that there should be a neurophysiologic 
rationale in our reasoning. First we have to ask ourselves if we are able to detect the precise 
epileptic focus to be able to interfere with seizure generation, if not, we have to go for the 
disruption of the epileptic activity propagation. Either way we need to make sure we are in 
the correct location. From the anatomic point of view this should be easy, but several 
problems have to be faced. In case that we decide to go for seizure propagation we must 
target a precise anatomic region. The localization of the target is performed by the use of the 
current technology: stereotactic surgery, neuro-navigation, MRI, and neurophysiology. All 
expertise is needed to ensure the localization. Despite all these efforts, anatomy may be 
disrupted. This is particularly the case of reaching thalamic targets. We prefer patients 
whose thalamus and brainstem are intact and symmetric. MRI is used to verify position. 
Even so, the best-placed electrodes must have neurophysiologic confirmation. 
In the case of centromedian stimulation, detailed analysis of incremental response 
morphology, polarity, peak latency, and cortical distribution may aid in defining the 
relation of the stimulated area with specific anatomophysiologic systems within the 
centromedian nucleus. Electrocortical responses produced by acute electrical stimulation 
along the centromedian nucleus or other structures are described in detail elsewhere 
(Velasco M, 1996).  
To perform the physiologic confirmation of the electrode position in the parvocellular 
portion, the three pairs of combinations of the four contacts in each DBS electrode are 
stimulated (0–1, 1–2, and 2–3). Unilateral stimulation is performed at 6 Hz, 1.0 ms, 320–800 
μA with 10-s duration to induce recruiting responses, and unilateral high frequency is 
conducted as well at 60 Hz, 1.0 ms, 320–800 μA to induce focalized desynchronization and 
negative DC shift of the EEG baseline. Scalp distribution analysis of electrocortical responses 
is performed. Within CM, suprathreshold stimulation in parvocellular subnucleus induces 
monophasic negative waxing and waning potentials, with peak latencies from 40 to 60 ms, 
recorded bilaterally in frontal and central regions, with emphasis on the stimulated side. 
Outside this subnucleus, incremental responses remain mainly biphasic positive-negative, 
with 16- to 20 ms latency, fixed amplitudes for the positive component, and distribution 
extending more toward the posterior leads. If the electrode is localized in the posterior and 
basal area of the centro median nucleus within boundaries with the parafascicular nucleus 
induces only short-latency positive potentials at low frequency and occasionally painful 
sensation at high frequencies (Velasco 1998). 
In the case of epileptic focus stimulation, localizing the precise site where it is located is 
mandatory; it could make the difference in seizure outcome. In our Epilepsy Clinic, patients 
are implanted with externalized diagnostic multicontact intracranial electrodes, and 
recorded outside the operating room to be able to detect spontaneous seizures. This is to 
ensure we know where the focus is located (figure 4). In case of hippocampal stimulation we 
implant bilateral hippocampal electrodes, if the focus is unilateral, the diagnostic electrodes 
are explanted and only a single therapeutic permanent electrode is implanted; if the patient 
has bilateral foci, two electrodes, one in each hippocampus is implanted. The selected 
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stimulation contacts are those that overlap with the epileptic focus (figure 5). All electrode 
implantations are verified with MRI.  
 
 
Fig. 4. Primary motor cortex epilepsy focus detection 
This figure illustrates a patient with two grids localized in the right front central cortex to 
detect a seizure focus in the primary motor area of the  right hand. 2A shows the patient’s 
parasagittal MRI with the right hemispheric grids and 2B depicts the EEG recording of a 
spontaneous simple partial seizure of the left hand.  
Maybe one of the topics that is most discussed and where no last word has been spoken 
refers to the stimulation parameters. We face many problems in this matter; probably the 
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most important is the lack of sufficient financing resources that are required for the 
implementation of double-blinded protocols. To this problem we might add the necessity 
for more basic research data, multicentric studies, approval of FDA or similar agencies in 
different countries. Despite all this, there are some suggestions of the current parameters 
used for epilepsy: 
  
Fig. 5. Bilateral hippocampal electrodes for diagnosis and neuromodulation therapy 
This figure depicts a patient with mesial temporal lobe epilepsy in whom bilateral 
hippocampal electrodes were implanted to determine focus. Recordings of spontaneous 
seizures demonstrated bilateral foci in most anterior contacts (left MRI); therefore bilateral 4 
contact therapeutic electrodes were directed to the amygdalo-hippocampal areas to 
stimulate the patient in a bilateral fashion (right MRI) 
4.2 Should we use cycling or continuous stimulation? 
The electrical stimulation cycling mode of the nervous tissue was originally proposed to 
avoid electrical current overcharge in areas under or around electrodes, and therefore 
damaging neural tissue (Cooper, 1976). Discontinuous and cycling ES have been 
successfully used in treatment epilepsy (Ebner 1980, Davis 1992, George 2000). Although the 
main reason for using this mode of stimulation has been to save battery charge, its efficacy 
indicates that the beneficial effect outlasts each stimulation period.  
4.3 What amplitude should we use? 
Information derived from basic research has showed the importance of setting stimulation 
parameters that take into account principally the charge density-per-phase, which for 
safety’s sake should not exceed 4 μC/cm2/phase (Babb 1977, Ebner 1980). In all of our CM 
stimulation cases, the stimulating pulse amplitude remained between 2.0 and 3.0 V while in 
hippocampus and motor cortex stimulation up to 3.5 V and only rarely were they changed 
during follow-up. This voltage represents between 50-80% of that which is necessary for 
inducing recruiting responses and DC shifts. It is important to mention that in cases with 
poor outcome, increasing the voltage 2 or 3 times the average did not improve efficacy.  
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4.4 Should we use high or low frequency stimulation? 
Experience on neuromodulation studies in patients with movement disorders and those 
with pain, it is known that high frequency stimulation inhibits both. The same occurs in 
epilepsy; almost all studies use frequency in the range of 130 Hz. Velasco M et al (1997) 
demonstrated that low frequencies produced recruiting responses when stimulating the CM 
nuclei, and when bilateral stimulation at 3 Hz was performed in these nuclei, a typical 
absence seizure was reproduced. On the contrary, high frequency stimulation produced 
cortical inhibition of epileptic activity. In the case of neuromodulation of the subthalamic 
nucleus, low frequency has been used for good results (Chabardès 2002).  
4.5 Open or closed loop mode? 
Recent instances of clinical application of closed-loop seizure control, which are limited to 
stimulation with pulse trains in response to epileptiform activity, have been reviewed 
(Osorio et al 2001, Sun et al 2008). This method requires the implementation of a seizure 
detection algorithm to control the delivery of therapy using a suitable device. The theory is 
that stimulation therapy is provided as needed, potentially reducing the likelihood of 
functional disruption or habituation due to continuous treatment. It should also be better to 
save battery of the pulse generator reducing costs. Questions regarding the cost of a dual 
system (for detection and for stimulation) is one problem with this stimulation mode, we are 
currently dealing with the high cost of the stimulating system, most patients will not be able 
to pay for a detection system too. Secondly, there are currently no data that support that 
there is a potential likelihood of functional disruption with neuromodulation. Third, 
nowadays there are rechargeable batteries so the need to save energy should not be an issue. 
But more important is the fact that there are still many problems for precise seizure 
detection bringing as a result the application of unnecessary stimuli due to false positive 
detection or failure to stimulate if we modify seizure detection parameters to avoid the 
former. Probably this is the reason why studies have shown that stimulating with a closed 
loop mode takes much longer to reach best results. Further studies are mandatory to 
improve this methodology and solve issues regarding efficacy of the closed loop mode and 
cost of a implanting a dual system. 
5. How can we make sure that neuromodulation is being adequately 
performed? 
Neuromodulation in epilepsy has certain difficulties for its long-term assessment due to 
several reasons: 
 The inherent characteristics of the symptoms (seizures)  
 Patients do not experiment any sensations or secondary effects at all that indicate that 
stimulation is being delivered 
 The time that neuromodulation takes to show a positive effect in seizure reduction  
  “Carry on” effect 
 Unlike movement disorders like tremor in Parkinson’s disease, seizures appear once in 
a while and are not predictable, so it is not a matter of turning the pulse generator on or 
off and observing if seizures disappear to know if the stimulation system is working. 
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Except for the dysphonia that a few patients who undergo vagus nerve stimulation 
experiment when the stimulator is ON, other patients do not have sensations or 
secondary effects that could indicate if the stimulation is taking place. Two other 
important observations are that stimulation takes a variable time to show its effect, this 
period can take from several days to months; and that, when stimulation is stopped, 
there is a variable period of “carry-on” effect This term refers to the observed 
phenomenon in which the seizure reduction is maintained for days to months after the 
stimulator is turned OFF, the battery depletes or the stimulation is interrupted for any 
reason. Seizures reappear later in a progressive manner without reaching basal (before 
neuromodulation) level either in number or severity. Today, the neuromodulation 
community accepts the “carry-on effect”.  
These inherent characteristics carry the need to check the system every 6 to 12 months or 
when the patient returns to consult us because seizures are increasing in intensity or 
number. This check up consists in: 
 Verifying pulse generator battery current: the pulse generator computer reader can tell 
us if the pulse generator has more than 50% or is running low. 
 Checking electrode impedance (we have a comparative with our immediate post 
operatory measurements). If there is an increase, it could mean that that either the 
system extension or the electrode are broken or disconnected. In this case simple X rays 
are mandatory. 
 Perform acute stimulation trial using the internalized stimulating system to generate 
recruiting responses. This will allow us to know that the system is working correctly 
and that the brain tissue is being stimulated, if not, either the system is broken or 
there is something in the tissue that is preventing a correct stimulation (blood, 
gliosis). Also the recruiting responses distribution in the scalp EEG can show us if the 
electrode moved from its intended placement. Within centromedian nucleus, 
suprathreshold stimulation in parvocellular subnucleus induces monophasic negative 
waxing and waning potentials, with peak latencies from 40 to 60 ms, recorded 
bilaterally in frontal and central regions, with emphasis on the stimulation side 
(Velasco 2006). Similar responses are found in hippocampal stimulation but are 
localized in ipsilateral temporal region and in motor cortex stimulation localized in 
ipsilateral frontal region. 
6. What happens to the brain function if we stimulate it? 
One of the main reasons to use neuromodulation is to preserve the functional areas of the 
brain. Neuromodulation in cases of abnormal movements or chronic pain has proven to be 
effective and to preserve function. Even when some undesirable effects are present, 
stimulation parameters and even the stimulated contacts can be changed and the adverse 
effects revert. When our group started stimulation of the centromedian thalamic nuclei for 
seizure control, we were dealing with patients with severe epilepsy, some of them Lennox-
Gastaut patients with relentless psychomotor worsening due to the amount and severity of 
their seizures. The surgical options were not going to spare any function. So the functional 
implications of neuromodulation were not our main concern and we knew that the method 
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was reversible. What we did not expect to find was an important improvement in the 
functions of these patients. We were surprised of how bed-ridden, totally dependent 
patients would start “learning” again. So we started evaluating their progress. 
Neuropsychological evaluation of this group was for the most part difficult in view of 
their deteriorated condition; several patients were in non-convulsive status, which made 
it impossible to apply a battery of standardized psychological tests in basal conditions. 
Nevertheless, the ability scales demonstrated that no patient had signs of neurologic or 
mental deterioration during electrical stimulation of the centromedian nuclei (Velasco et 
al 1993a, Velasco et al 2006), on the contrary, all patients improved their scales, some of 
them becoming independent and a couple of them seizure free and living a normal life. 
Patients with normal development before Lennox-Gastaut syndrome onset tend to regain 
their abilities regardless of convulsive syndrome severity (figure 6). Patients who had an 
early childhood onset had to learn everything from the start. The seizure and medication 
reduction added to the normalization of EEG background activity could explain this 
improvement (Velasco et al 1993b). Another explanation is that we are stimulating the 
reticular formation and thus improving the attention mechanisms of the brain, if a patient 
attends, he is able to learn new tasks.  
In patients with neuromodulation of the hippocampal focus, using pulse amplitudes higher 
than needed, not only are the clinical benefits not increased but speech problems suchs as 
anomia can be produced. The problem disappears when the amplitude is decreased again  
(Nuche-Bricaire 2010). 
 
 
 
Fig. 6. Lennox-Gastaut syndrome response to neuromodulation 
This figure illustrates the progress of a seven year-old patient with Lennox-Gastaut 
syndrome performing a neuropsychological battery. On the left image the patient has spent 
5 minutes trying to copy a single figure with no success. The picture on the right shows 
same patient after 6 months with electrical stimulation of the thalamic centromedian nuclei. 
He is performing the same task but was able to copy several figures that were being 
presented to him in a couple of minutes paying attention to instructions and copying figures 
quite well despite they increased in difficulty and details. 
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In regard to stimulating the epileptic focus localized in the hippocampus, the groups 
mentioned above that have performed neuromodulation of the hippocampal foci have not 
reported a worsening of the memory function. Neuropsychological batteries for memory 
function (Table 2) have been applied and no deterioration has been found, and possibly a 
tendency to improve has occurred (Velasco 2007). The same thing happens with patients 
with stimulation of the primary or supplementary motor cortices, no decrease in motor 
function has been observed (Velasco 2009). Numbers or patients are small up to now and 
more studies need to be performed. 
 
Function tested Test 
Attention and memory Neuropsi Attention and Memory Battery 
Verbal memory Rey verbal learning 
Verbal memory Digit Counting 
Verbal memory Logic memory 
Non verbal memory Visual reproduction 
Non verbal memory  Wind Mill visual spatial Bezares Test 
    
Language dominance Dichotic listening test 
Table 2. Neuropsychological battery for memory function 
This table illustrates the neuropsycological tests that are performed in a patient with 
intractable mesial temporal lobe epilepsy. In left column we point the function that testing is 
aimed for and on the right the specific test. This battery is accompanied with general testing 
as for example IQ and depression scales.  
7. What have we learned about the possible mechanisms that explain why 
neuromodulation controls seizures? 
In 2000 Velasco et al published the first results of subacute hippocampus foci stimulation in 
10 patients. These patients had undergone intracranial electrode implantation as part of 
their surgical protocol to localize the epileptic focus; once localized, a two- to three-week 
trial of subacute stimulation was delivered before performing temporal lobectomy. This 
study design allowed the performance of a number of neurophysiologic (afterdischarges, 
paired pulse trials before and after stimulation), and single-photon- emission computed 
tomography (SPECT) studies comparing basal conditions with post-stimulation 
conditions. Since patients underwent lobectomy, stimulated tissue was recovered and 
analyzed using high- performance liquid chromatography (HPLC) techniques (Cuéllar-
Herrera 2004). All studies suggested an inhibitory mechanism to explain seizure control 
(Figure 7). Wyckhuys T et al (2007) found that afterdischarges were inhibited and seizures 
disappeared in rats that had been kindled to induce epileptic seizures. None of the rats 
had an increase in seizure number. 
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Fig. 7. Possible mechanisms that explain how neuromodulation works 
This figure exemplifies the possible mechanisms through which neuromodulation works in 
hippocampal stimulation in man. Upper image is a single emission photon computerized 
study in a patient who underwent neuromodulation of the hippocampus for 3 weeks. At the 
lower left is the recording of afterdischarges in same patients in whom we apply maximum 
stimulation intensity in the epileptic focus and can no longer produce a clinical seizure and 
barely a few spikes instead of a prolonged afterdischarge accompanied by clinical 
symptoms of a complex partial seizure identical to the spontaneous ones presented by the 
patients. The lower right shows the difference between the recovery cycles before 
(continuous line) and after (broken line) neuromodulation. All three studies suggest an 
inhibitory effect of neuromodulation of the hippocampus. 
8. Conclusion 
This chapter shows a brief summary of the principal work that has been performed all over 
the world regarding neuromodulation for epilepsy. Results are encouraging; 
neuromodulation is a reversible surgical alternative that preserves neural function. It is 
capable of reducing seizure frequency and severity to a point that can be superior to what 
new generation antiepileptic medications have shown (Chadwik 2001, Van Rijckevorsel & 
Boon 2001) without their adverse effects. Patients tolerate it well, as a matter of fact, they are 
not even aware of being stimulated (except for vagus nerve stimulation). More concerns 
exist: are there other stimulation parameters worth trying (frequency, amplitude, pulse 
width), should they change according to the target; what is the best stimulation mode (open 
loop or close loop); are there other mechanisms that explain its antiepileptic effect? What 
will eventually happen in a longer follow up period?  
Challenges are huge: exploring new targets, improving technology (better and cheaper 
stimulation and probably seizure detection systems, wider range of electrodes to choose 
from, smaller stimulating systems for younger children), improvement of surgical 
techniques so that we can find the focus and stimulate through the same electrode eluding 
unnecessary surgical procedures.  
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The main steps to be able to perform research in this matter have been taken; epilepsy expert 
groups tend to agree that neuromodulation is a field that can bring seizure relieve to 
patients. To be able to solve the questions and challenges, multidisciplinary, 
interinstitutional, worldwide projects with well thought designs are necessary.  
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